Views & Analysis | Perspectives on pharma industry issues

Oncology

On GDF-15 neutralisation and cachexia, with CatalYm

As ESMO 2026 continues to get underway, pharmaphorum web editor Nicole Raleigh spoke with Scott Clarke, CEO of CatalYm.

Oncology

pharmaphorum podcast Episode 282 at ESMO26: Dr Chuck Link, Syncromune

ESMO26: Lowering toxicity, extending lives, with Syncromune

As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.

Oncology

Why precision biomarkers will change the future of breast ca...

Blood-based biomarkers can provide an earlier, dynamic view of what is happening inside a patient, creating an opportunity to detect changes sooner.

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Articles

Suzanne Murray and Thomas Kellner share their thoughts on the current CME landscape in Europe and how they think outcomes should be measured in CME. As our medical communications month continues, we speak with Suzanne Murray, founder of AXDEV Group International, and Thomas Kellner, Managing Partner at AXDEV Europe.

Articles

CME: unifying European standards and focusing on the needs o...

Professor Robin Stevenson shares his thoughts on how we can unify standards in CME across Europe. Professor Robin Stevenson is a retired respiratory physician. He was president of the European Board for Accreditation in Pneumology (EBAP)...

Articles

How does global PR get local in social media?

As our discipline focus this month is medical communications, Ed Purkis discusses the influence of social media on global PR strategies in the context of healthcare communications. We live in an increasingly globalised world and healthcare communications is no exception. More than any other year, 2012 has seen a…

Sales & Marketing

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital